Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-335538

Chief Executive Officer gave up 306,846 shares (to pay taxes)

  • Chief Executive Officer acquired 550,000 shares (option exercise)
  • Chief Executive Officer gave 243,154 shares (gift)
  • Chief Executive Officer acquired 243,154 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BELANOFF JOSEPH K Chief Executive Officer 2025-12-24 Option exercise +550,000 $3.88 $2,134,000 550,000 D: show line 1 in the form
BELANOFF JOSEPH K Chief Executive Officer 2025-12-24 Shares withheld for taxes −306,846 $83.59 $25,649,257 243,154 D: show line 2 in the form
BELANOFF JOSEPH K Chief Executive Officer 2025-12-24 Gift −243,154 0 D: show line 3 in the form
BELANOFF JOSEPH K Chief Executive Officer 2025-12-24 Other acquisition +243,154 2,944,524 I: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BELANOFF JOSEPH K Chief Executive Officer 2025-12-24 Option exercise · Stock option (right to buy) −550,000 0 D: show line 5 in the form
Loading xslF345X05/ownership.xml…